← Back to Search

Culturally-tailored Smoking Cessation Program for Quitting Smoking

N/A
Recruiting
Led By Lisa Carter-Bawa, PhD
Research Sponsored by Hackensack Meridian Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up post intervention completion - at 6 weeks
Awards & highlights

Study Summary

This trial compared two programs to help African American women quit smoking: one was tailored to the group, the other to individuals.

Who is the study for?
This trial is for African American women who currently smoke at least 5 cigarettes daily and have been doing so for the past year. They must be in good health, as determined by their medical history, and able to give informed consent. It's not open to pregnant women, those with cardiovascular or lung diseases, mental illness, prisoners, or anyone unable to consent.Check my eligibility
What is being tested?
The study is testing two different tobacco cessation programs over a period of 6 weeks. One program offers culturally tailored advice through newsletters while the other provides personalized culturally-tailored guidance. The goal is to see which method helps more in quitting smoking.See study design
What are the potential side effects?
Since this trial involves behavioral interventions like receiving newsletters and counseling rather than medication, there are no direct side effects from drugs; however participants may experience stress or anxiety related to attempting smoking cessation.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~post intervention completion - at 6 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and post intervention completion - at 6 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Accessibility and Satisfaction of the 6-week tobacco treatment intervention
Feasibility of the 6-week tobacco treatment intervention
Secondary outcome measures
Effectiveness of the intervention

Trial Design

2Treatment groups
Active Control
Group I: Culturally-tailored Tobacco Treatment InterventionActive Control2 Interventions
Upon consent, participants will complete a baseline survey, receive the home Carbon monoxide monitor and instructions on how to use, and be scheduled for weekly telephone calls with a certified tobacco treatment specialist (CTTS) for 6 weeks. The culturally-tailored tobacco intervention content by week via telephone call with the CTTS includes among others: Reasons and Motivations for Quitting, Benefits of Quitting, Stress Management and Discussion about Environmental Influences. Participants will also receive weekly Culturally-tailored Content Newsletters emailed after their weekly cessation counseling session.
Group II: Preference-Driven Culturally-tailored Tobacco Treatment InterventionActive Control3 Interventions
Upon consent, participants will complete a baseline survey, receive the home Carbon monoxide monitor and instructions on how to use, and be scheduled for weekly telephone calls with a certified tobacco treatment specialist (CTTS) for 6 weeks. The culturally-tailored tobacco intervention content by week via telephone call with the CTTS includes among others: Reasons and Motivations for Quitting, Benefits of Quitting, Stress Management and Discussion about Environmental Influences. Participants will complete the one-item Control Preference Scale and receive either an Active Content Newsletter or Passive Content Newsletter emailed after their weekly cessation counseling session.

Find a Location

Who is running the clinical trial?

Hackensack Meridian HealthLead Sponsor
131 Previous Clinical Trials
28,224 Total Patients Enrolled
Lisa Carter-Bawa, PhDPrincipal InvestigatorHackensack Meridian Health
2 Previous Clinical Trials
600 Total Patients Enrolled

Media Library

Culturally-tailored Tobacco Treatment Clinical Trial Eligibility Overview. Trial Name: NCT05878990 — N/A
Smoking Cessation Research Study Groups: Culturally-tailored Tobacco Treatment Intervention, Preference-Driven Culturally-tailored Tobacco Treatment Intervention
Smoking Cessation Clinical Trial 2023: Culturally-tailored Tobacco Treatment Highlights & Side Effects. Trial Name: NCT05878990 — N/A
Culturally-tailored Tobacco Treatment 2023 Treatment Timeline for Medical Study. Trial Name: NCT05878990 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this experiment currently enrolling participants?

"According to the data on clinicaltrials.gov, this trial is presently recruiting participants with its initial posting date being April 25th 2023 and last edit occurring May 18th 2023."

Answered by AI

Does the trial extend to octogenarians?

"The age restriction for this clinical trial is between 18 and 69. For those who are younger than that, there are 5 separate trials available; meanwhile 131 studies accommodate elderly patients."

Answered by AI

Could I participate in this trial?

"To qualify for this research, individuals must have a history of smoking cessation and lie between the ages 18 and 69. This study is currently looking to recruit 20 participants."

Answered by AI

What is the current scope of participation in this clinical research?

"Yes, the data on clinicaltrials.gov indicates that this research project is actively accepting volunteers. The study was initially published on April 25th 2023 and subsequently updated on May 18th 2023. Researchers are hoping to enrol up to twenty participants from a single medical centre."

Answered by AI

Who else is applying?

What site did they apply to?
Hackensack Meridian Health - Center for Discovery and Innovation
What portion of applicants met pre-screening criteria?
Did not meet criteria
Met criteria
How many prior treatments have patients received?
3+

Why did patients apply to this trial?

To try to stop smoking.
PatientReceived no prior treatments
~0 spots leftby May 2024